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ENTOMOPHTHORAMYCOSIS BY Conidiobolus coronatus. REPORT OF A CASE SUCCESSFULLY
TREATED WITH THE COMBINATION OF ITRACONAZOLE AND FLUCONAZOLE
Antonio Carlos Francesconi do VALLE(1), Bodo WANKE(2), Márcia dos Santos LAZÉRA(2), Paulo Cezar Fialho MONTEIRO(2) & Maria de Lourdes VIEGAS(3)
SUMMARY
Rhinoentomophthoramycosis caused by Conidiobolus coronatus in a 61-year old woman was unsuccessfully treated during 8
years with all the antifungals available in the Brazilian market, including potassium iodide for 1 month, sulfamethoxazole plus
trimethoprim for 2 months, amphotericin B, total dose of 1130 mg, cetoconazole, 400 mg/day for 6 months, fluconazole, 200 mg/day,
for at least 2 months and, itraconazole, 400 mg/day for 2 months, followed by 200 mg/day for 4 more months. Complete clinical and
mycological cure was achieved using itraconazol 400 mg/day in association with fluconazol 200 mg/day during 24 months. After
cure she was submitted to plastic surgery to repair her facial deformation. Today she remains clinically and mycologically cured after
59/60 months (5 years!) without any specific antifungal. We thus suggest the use of the combination of itraconazole and fluconazole
as an additional option for the treatment of this mycosis.
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INTRODUCTION
Entomophthoramycosis affects individuals with an apparently intact
immunological status and occurs primarily in tropical areas. Two
zygomycetes belonging to the order Entomophthorales are the etiologic
agents of subcutaneous entomophthoramycosis: Basodiobolus ranarum
(= B. haptosporus) and Conidiobolus coronatus3,7. C. coronatus has
already been isolated from soil samples, rotting plant matter, insects,
and the gastrointestinal contents of lizards and frogs, especially in tropical
and subtropical regions11.
Infection by B. ranarum manifests itself as a subcutaneous
tumefaction located on the trunk, buttocks, or proximal portion of the
limbs. Invasion of the abdominal and thoracic cavities by extension of
the subcutaneous tumor mass has been reported. More recently there
have been case reports with frankly visceral manifestations, with gastric
and intestinal tumoral lesions, presenting as acute abdomen3,7.
Lesions by C. coronatus begin as infiltration of the nasal mucosa
and submucosa, extending to the adjacent tissues of the paranasal sinuses,
nasal dorsum, upper lip, and face, with no delimitation to their growth.
The tumefaction, with a nodular or polipose infiltrative appearance, is
covered by erythematous, hard skin, displaying continuity with the
underlying tissues. The clinical manifestations result from the expansion
of the tumor mass. Because of its initially central facial presentation
affecting the nose first, the disease is also known as rhinoentomo-
phthoramycosis. In the more advanced cases, the lesions can also affect
the nasopharynx, oropharynx, palate, cervical region, and even the
mediastinum3,7. The first mycologically proven cases in humans were
described independently and simultaneously in 1965 in Jamaica4 and
Africa12.
Cases of rhinoentomophthoramycosis have been described in Africa,
Asia, and the Americas, ranging between the tropics of Cancer and
Capricorn. The disease is essentially chronic, evolving over the course
of years. No incubation period or cases of spontaneous involution are
known. Diagnosis is made by clinical, histopathological, and mycological
examination2.
According to the medical literature, treatment can be applied with
satisfactory results using potassium iodide, amphotericin B, and
cetoconazole. However, the literature provides little information on long-
term follow-up and/or relapses. We present a case of rhinoentomo-
phthoramycosis caused by C. coronatus in which all the available
antifungals, including itraconazole and fluconazole, had been used singly
without success. However, the patient evolved to complete cure after
long-term combination therapy with these two triazoles.
CASE REPORT
A 61 year-old white woman, domestic, living in the state of
Maranhão, northeast Brazil, presented a history of a disease lasting 8
234
VALLE, A.C.F.; WANKE, B.; LAZÉRA, M.S.; MONTEIRO, P.C.F. & VIEGAS, M.L. - Entomophthoramycosis by Conidiobolus coronatus. Report of a case successfully treated with the
combination of itraconazole and fluconazole. Rev. Inst. Med. trop. S. Paulo, 43(4):233-236, 2001.
years (Fig. 1). During this period she was examined at several hospitals,
and after obtaining the diagnosis of entomophthoramycosis based on
clinical, mycological and histopathological findings, treated with the
following drugs:
- potassium iodide for 1 month, with worsening of the lesions;
- sulfamethoxazole plus trimethoprim for 2 months, with no
therapeutic response;
- amphotericin B, total dose of 1130 mg, with partial improvement;
- cetoconazole, 400 mg/day for 6 months, with a favorable clinical
response. Treatment was interrupted because the patient could not
afford the medication. After a relapse, she resumed use of this
medication, with no therapeutic response;
- fluconazole, 200 mg/day, for at least 2 months, with no therapeutic
response;
- itraconazole, 400 mg/day for 2 months, followed by 200 mg/day for
4 more months, with no therapeutic response.
The patient was referred to the Evandro Chagas Hospital at the
Oswaldo Cruz Foundation in Rio de Janeiro for specific treatment, where
the diagnosis of rhinoentomophthoramycosis by C. coronatus was
confirmed on clinical, histopathological, and mycological examination
(Fig. 2a and 2b). At the beginning of April 28, 1993, due to the lack of
other treatment options, we initiated combined oral fluconazole 200 mg/
day and itraconazole 400 mg/day until April 1995. The patient evolved
to clinical and mycological cure in 3 months (Fig. 3). Throughout
treatment she was monitored every 2 months with clinical and
mycological examination, complete blood count, and blood biochemical
tests and presented no side effects or signs of toxicity. After the specific
clinical treatment during 24 months, restorative surgery was performed
to correct sequelae (Fig. 4). At the last clinical assessment, in March
2000, the patient had been off medication for 59 months and remained
clinically cured.
DISCUSSION
Entomophthoramycosis occurs sporadically in tropical regions of
Asia, Africa, and the Americas. The disease is caused by fungi living
saprophytically in organic debris in the environment. So far only few
cases of rhinoentomophthoramycosis caused by C. coronatus were
reported. In Brazil, the first case was described by ANDRADE et al. in
19671, only two years after the first reports on this mycosis in cases
from Africa and Jamaica. Later on, cases were reported from the states
of the North9,10 and more frequently from the Northeast of Brazil (states
of Bahia, Piauí, Maranhão, and Sergipe)1,2,6,8,14,17. In the present case the
patient was a native of the state of Maranhão, reinforcing the Northeast
as the main focus of this mycosis in Brazil.
Clinical and histopathological findings are quite suggestive, but
definitive diagnosis is only possible by isolating and identifying the
fungus in appropriate culture media. Clinically, the differential diagnosisFig. 1 - Aspect of the patient at admission.
Fig. 2a - Culture of Conidiobolus coronatus. Fig. 2b - Microphotograph showing sporangiola producing secondary multiplicative spores.
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should consider scleroma, rhynosporidiosis, and benign and malignant
tumors of the nasal cavity 8. Histopathological examination shows an
inflammatory granulomatous reaction, with a predominantly
mononuclear infiltrate consisting of lymphocytes, histiocytes, and some
multinucleated giant cells, along with plasma cells and eosinophils. The
central portion shows broad, thin-walled, irregular branching hyphae,
frequently approaching right angles. These hyphae do not usually display
septa and are surrounded by a peculiar eosinophilic mass (the Splendore-
Hoeppli phenomenon). The appearance is similar to that of subcutaneous
entomophthoramycosis caused by B. ranarum. In our clinical case the
diagnosis was based on clinical and histopathological examination
confirmed by mycological identification of C. coronatus.
According to the literature, treatment of rhinoentomophthoramycosis
has been performed successfully with potassium iodide3, combination
sulfamethoxazole-trimethoprim5, amphotericin B3,5, and cetoconazole8,17.
All of these drugs were used unsuccessfully in the present case.
Itraconazole and fluconazole, broad-spectrum triazolic derivative
antifungals were used effectively against various other mycoses, had
also been used singly to treat the patient, initially producing regression
of the lesions, but with reactivation of the infection shortly afterwards.
All the antifungals available in Brazil in 1993 failed to cure the patient.
Saperconazole, a new broad-spectrum imidazolic derivative, also was
not available at that time because it has been removed from the market
due to the development of tumors in laboratory animals. For lack of
other options and based on reports of the successful use of multidrug
therapy in various infectious diseases, we used a combination of
itraconazole and fluconazole obtaining an excellent therapeutic response.
In fact, the response was similar to that found by other authors in treating
other mycoses with this combination therapy13,15,16. No side effects or
drug-related toxicity were observed. We thus suggest the use of the
combination of itraconazole and fluconazole as an additional option for
the treatment of this mycosis. Possibly this may be also valid for other
disseminated or opportunistic mycoses, especially in cases following
treatment failure with the classic drug regimens.
Itraconazole and fluconazole are triazoles with similar mechanisms,
acting especially on the fungal cell wall’s cytochrome p450. However,
the underlying mechanism of a possible synergism between both drugs
is so far unknown. We didn’t find reports of antagonism between these
two drugs.
Due to the lack of criteria for control of biological cure in this mycosis
and the small number of cases reported in the literature, treatment is
somewhat empirical, since the precise dosage and duration of treatment
are unknown. In our case, as in others reported in the literature, there
had been an initially favorable response to certain drugs, but their removal,
perhaps too early, had led to in vivo resistance. Therefore, even with a
clinical cure after 3 months, we maintained this combination drug therapy
for over 19 months. There is a report of cure in this mycosis following
surgical treatment, but in our case surgery was performed to correct
sequelae, and the successive histopathological and mycological tests of
the operatory specimens were negative.
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Fig. 4 - Aspect of the patient after 24 months of successful therapy and restorative surgery.Fig. 3 - Aspect of patient’s lesion 90 days after the use of the
combination of itraconazole and fluconazole.
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RESUMO
Entomoftoramicose por Conidiobolus coronatus. Relato de um
caso tratado com a associação de itraconazol com fluconazol
É relatado um caso de rinoentomoftoramicose por Conidiobolus
coronatus em mulher de 61 anos submetida a tratamento com todos os
antifúngicos disponíveis no mercado brasileiro, durante 8 anos, sem
sucesso, incluindo iodeto de potássio por 1 mês, sulfametoxazol associado
ao trimetoprim por 2 meses, anfotericina B em dose total de 1130 mg,
cetoconazol, 400 mg/dia por 6 meses, fluconazol, 200 mg/dia, por pelo
menos 2 meses, e itraconazol, 400 mg/dia, por 2 meses, seguido de 200
mg/dia por mais 4 meses. A cura clínica e micológica completa foi obtida
com a associação de itraconazol 400mg/dia com fluconazol 200 mg/dia,
durante 24 meses. Após a cura a paciente foi submetida a cirurgia
restauradora. Atualmente a paciente encontra-se há 59 meses sem
medicação específica permanecendo clínica e micologicamente curada.
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